tiprankstipranks
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market
Holding VIR?
Track your performance easily

Vir Biotechnology (VIR) Ownership - Who Owns Vir Biotechnology?

1,189 Followers

Vir Biotechnology (VIR) Ownership Overview

51.49%14.45%20.48%13.58%
51.49% Insiders
20.48% Other Institutional Investors
― ETFs
13.58% Public Companies and Individual Investors
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. , 51.49% is owned by Insiders, and 13.58% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 12, 2024
xxxxxxxxxxxxx
$43760
Apr 04, 2024
Marianne De Backer
Ceo,director
xxxxxxxxxxxxx
$689803
Apr 02, 2024
Ann M. Hanly
Evp & Cto
xxxxxxxxxxxxx
$27246
Mar 28, 2024
Sung Lee
Evp & Cfo
xxxxxxxxxxxxx
$59359

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
11,196,037Institution8.23%104,906,867
10,365,172Institution7.62%97,121,662
8,851,812Institution6.51%82,941,478
3,119,529Institution2.29%29,229,987
896,355Institution0.66%8,398,846
835,489Institution0.61%7,828,532
769,000Institution0.57%7,205,530
669,971Institution0.49%6,277,628
643,470Institution0.47%6,029,314
566,807Institution0.42%5,310,982

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
8,851,812Institution6.51%82,941,478
896,355Institution0.66%8,398,846
835,489Institution0.61%7,828,532
769,000Institution0.57%7,205,530
669,971Institution0.49%6,277,628
566,807Institution0.42%5,310,982
545,129Institution0.40%5,107,859
509,461Institution0.37%4,773,650
497,094Institution0.37%4,657,771
409,998Institution0.30%3,841,681

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,642,277Institution4.15%52,868,135
3,457,160Institution2.54%35,505,033
2,743,016Institution2.02%28,170,774
2,191,700Institution1.61%20,075,972
1,562,728Institution1.15%16,049,217
1,349,654Institution0.99%13,860,947
1,482,642Institution1.09%13,581,001
941,504Institution0.69%8,821,892
835,117Institution0.61%7,649,672
747,600Institution0.55%6,848,016

FAQ

Who Owns Vir Biotechnology (VIR)?
According to the latest TipRanks data, approximately 20.48% of the company's stock is held by institutional investors, 51.49% is held by insiders, and 13.58% is held by retail investors.
    What percentage of Vir Biotechnology (VIR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 20.48% of Vir Biotechnology (VIR) stock is held by institutional investors.
      What percentage of Vir Biotechnology (VIR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.58% of Vir Biotechnology (VIR) stock is held by retail investors.
        Who owns the most shares of Vir Biotechnology (VIR)?
        iShares owns the most shares of Vir Biotechnology (VIR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis